Latest News, Updates & Breaking Headlines
NEW DELHI: Several domestic companies including Sun Pharma, Torrent, Zydus, Dr Reddy’s, Glenmark and Alkem announced the launch of semaglutide on Day 1, substantially lowering the cost of weight-loss therapy.This is in the wake of the innovator Novo Nordisk losing its patent on semaglutide on March 20.Sun Pharma’s weekly therapy costs, from initiation to the…
The impending patent expiry of semaglutide drugs across India, emerging markets and select regulated markets such as Canada and Brazil is expected to create a revenue opportunity of more than Rs 50 billion for generic pharmaceutical companies over the next 12 to 15 months, according to an industry update by Systematix Institutional Research.The report said…
Doctors often prescribe semaglutide to help people manage type 2 diabetes or drop extra weight. Lately, though, its knack for shielding the heart has cardiologists buzzing. A deep dive into the SELECT trial reveals benefits that show up fast and stick around, even if the scale barely budges. This shift could change how we tackle…
